385 related articles for article (PubMed ID: 35583175)
1. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
2. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
[TBL] [Abstract][Full Text] [Related]
3. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.
Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348
[TBL] [Abstract][Full Text] [Related]
4. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Penn-Nicholson A; Georghiou SB; Ciobanu N; Kazi M; Bhalla M; David A; Conradie F; Ruhwald M; Crudu V; Rodrigues C; Myneedu VP; Scott L; Denkinger CM; Schumacher SG;
Lancet Infect Dis; 2022 Feb; 22(2):242-249. PubMed ID: 34627496
[TBL] [Abstract][Full Text] [Related]
5. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
Kay AW; Ness T; Verkuijl SE; Viney K; Brands A; Masini T; González Fernández L; Eisenhut M; Detjen AK; Mandalakas AM; Steingart KR; Takwoingi Y
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013359. PubMed ID: 36065889
[TBL] [Abstract][Full Text] [Related]
6. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
[TBL] [Abstract][Full Text] [Related]
7. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
8. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.
Zifodya JS; Kreniske JS; Schiller I; Kohli M; Dendukuri N; Schumacher SG; Ochodo EA; Haraka F; Zwerling AA; Pai M; Steingart KR; Horne DJ
Cochrane Database Syst Rev; 2021 Feb; 2():CD009593. PubMed ID: 33616229
[TBL] [Abstract][Full Text] [Related]
9. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
10. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.
Horne DJ; Kohli M; Zifodya JS; Schiller I; Dendukuri N; Tollefson D; Schumacher SG; Ochodo EA; Pai M; Steingart KR
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009593. PubMed ID: 31173647
[TBL] [Abstract][Full Text] [Related]
11. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
13. Screening tests for active pulmonary tuberculosis in children.
Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
Chen X; Li R; Ge S; Li Y; Cai C; Weng T; Zhang Y; Jiang J; Feng Z; Chen Y; Zhang Y; Ma J; Persing DH; Chen J; Tang YW; Sun F; Zhang W
J Clin Microbiol; 2023 Jun; 61(6):e0183222. PubMed ID: 37249422
[TBL] [Abstract][Full Text] [Related]
16. GenoType
Theron G; Peter J; Richardson M; Warren R; Dheda K; Steingart KR
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010705. PubMed ID: 27605387
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the performance of InnowaveDX MTB/RIF for the detection of
Wang YP; Tan YH; Li X; Wang J; Chen CG; Xu J; Xiang J
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):658-663. PubMed ID: 37402655
[No Abstract] [Full Text] [Related]
18. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Syed RR; Catanzaro DG; Colman RE; Cooney CG; Linger Y; Kukhtin AV; Holmberg RC; Norville R; Crudu V; Ciobanu N; Codreanu A; Seifert M; Hillery N; Chiles P; Catanzaro A; Rodwell TC
J Clin Microbiol; 2023 Mar; 61(3):e0147822. PubMed ID: 36757183
[TBL] [Abstract][Full Text] [Related]
19. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
[TBL] [Abstract][Full Text] [Related]
20. Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.
Cao Y; Parmar H; Gaur RL; Lieu D; Raghunath S; Via N; Battaglia S; Cirillo DM; Denkinger C; Georghiou S; Kwiatkowski R; Persing D; Alland D; Chakravorty S
J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]